Overview
Bloomberg‑compiled options data indicates that Abbott Laboratories (ticker ABT) may experience an implied price movement of up to 4.5% when it reports its quarterly earnings on July 16, 2026, prior to the market opening. This implied move reflects the market’s expectation of volatility surrounding the earnings announcement.
Historical Implied Move Performance
The article provides a record of the stock’s actual price changes versus the implied moves for the eight most recent earnings releases. In five of those eight instances, the actual move exceeded the implied forecast. Specific instances include:
- On April 16 (year not specified), the shares fell 7.8% against an implied move of 3.2%.
- In an unnamed January release, the stock dropped 13.1% while the implied move was 3.6%.
- In October 2025, the share price declined 2.7% with an implied move of 3.4%.
- On July 17, 2025, the shares fell 9.5% versus an implied move of 2.8%.
- In April 2025, the stock rose 4.6% compared with an implied move of 4.2%.
- On January 22, 2025, the shares gained 4.2% against an implied move of 3.1%.
- On October 16, 2024, the stock increased 2.8% while the implied move was 3.9%.
- On July 18, 2024, the shares fell 2.9% versus an implied move of 3.9%.
These figures illustrate a pattern where actual price swings have frequently been larger than the options‑derived expectations.
Publication Details
The piece was generated with the assistance of artificial intelligence and subsequently reviewed by an editor. It carries the Reuters copyright notice and includes a reference to the terms and conditions governing the content.